Retour
Fourchette du Jour
113,66 €
117,74 €
Fourchette 52 Semaines
102,97 €
175,77 €
Volume
403 004
Moyenne 50J / 200J
140,91 €
/
138,89 €
Clôture Précédente
116,35 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 134,0 | 0,3 |
| P/B | 3,1 | 2,9 |
| ROE % | 2,4 | 3,7 |
| Net Margin % | 6,6 | 3,8 |
| Rev Growth 5Y % | 2,4 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
177,50 €
+52.6%
Low: 150,00 €
High: 200,00 €
P/E Prévisionnel
58,5
BPA Prévisionnel
1,99 €
Croissance BPA (est.)
+0,0%
CA Est.
830 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
5,69 €
5,54 € – 5,79 €
|
1,5 B | 1 |
| FY2029 |
4,49 €
4,37 € – 4,56 €
|
1,3 B | 1 |
| FY2028 |
3,30 €
2,64 € – 3,79 €
|
1,1 B | 5 |
Points Clés
Revenue grew 2,43% annually over 5 years — modest growth
ROE of 2,40% is below average
Debt/Equity of 0,33 — conservative balance sheet
Generating 93,90M in free cash flow
P/E of 133,99 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13,93%
Croissance
Revenue Growth (5Y)
2,43%
Revenue (1Y)16,36%
Earnings (1Y)N/A
FCF Growth (3Y)11,94%
Qualité
Return on Equity
2,40%
ROIC1,60%
Net Margin6,62%
Op. Margin8,07%
Sécurité
Debt / Equity
0,33
Current Ratio8,37
Interest Coverage2,57
Valorisation
P/E Ratio
133,99
P/B Ratio3,11
EV/EBITDA112,04
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,36% | Revenue Growth (3Y) | 8,05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 17,20% |
| Revenue Growth (5Y) | 2,43% | Earnings Growth (5Y) | -21,43% |
| Profitability | |||
| Revenue (TTM) | 738,26M | Net Income (TTM) | 48,89M |
| ROE | 2,40% | ROA | 1,66% |
| Gross Margin | 47,09% | Operating Margin | 8,07% |
| Net Margin | 6,62% | Free Cash Flow (TTM) | 93,90M |
| ROIC | 1,60% | FCF Growth (3Y) | 11,94% |
| Safety | |||
| Debt / Equity | 0,33 | Current Ratio | 8,37 |
| Interest Coverage | 2,57 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 133,99 | P/B Ratio | 3,11 |
| P/S Ratio | 8,87 | PEG Ratio | -0,65 |
| EV/EBITDA | 112,04 | Dividend Yield | 0,00% |
| Market Cap | 6,55B | Enterprise Value | 6,68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 738,26M | 634,44M | 632,36M | 801,54M | 670,53M |
| Net Income | 48,89M | -25,51M | 35,60M | 185,96M | 128,29M |
| EPS (Diluted) | 0,86 | -0,46 | 0,63 | 3,24 | 2,24 |
| Gross Profit | 347,62M | 274,65M | 278,44M | 455,71M | 391,25M |
| Operating Income | 59,58M | -35,11M | 47,70M | 224,67M | 167,25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,95B | 2,83B | 2,83B | 2,53B | 2,36B |
| Total Liabilities | 843,57M | 856,95M | 866,34M | 620,90M | 608,29M |
| Shareholders' Equity | 2,11B | 1,97B | 1,96B | 1,91B | 1,75B |
| Total Debt | 689,95M | 686,25M | 711,80M | 422,96M | 366,05M |
| Cash & Equivalents | 566,02M | 757,36M | 751,32M | 523,46M | 603,81M |
| Current Assets | 1,14B | 1,07B | 1,11B | 998,12M | 931,68M |
| Current Liabilities | 135,83M | 126,79M | 164,94M | 404,20M | 375,26M |